Company:  ALLARITY THERAPEUTICS, IN ...
Form Type:  S-4/A
Filing Date:  10/18/2021 
CIK:  0001860657 
Address:  210 BROADWAY
SUITE 201
 
City, State, Zip:  CAMBRIDGE, Massachusetts 02139 
Telephone:  401-426-4664 
Fiscal Year:  12/31 
Register and access this filing in:     
  FORM S-4/A
    CALCULATION OF REGISTRATION FEE
    SUBJECT TO COMPLETION, DATED OCTOBER 18, 2021
    TABLE OF CONTENTS
    CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
    SUMMARY OF INFORMATION STATEMENT/PROSPECTUS
    The Recapitalization Share Exchange and the Reorganization ...
    Risk Factors
    Conversion of Compensatory Warrants Held by Management
    SUMMARY HISTORICAL FINANCIAL INFORMATION
    MARKET PRICE AND DIVIDEND INFORMATION
    Dividend Policy
    RISK FACTORS
    General Risk Factors
    United States Federal Income Tax Considerations
    Allarity's Business
      Competition
      Legal Proceedings
      NAME AND TITLE
    Executive Compensation and Director Compensation
      COMPENSATION TABLE
      OPTIONS
    2020 Non-Employee Director Compensation
      NAME AND TITLE
    SELECTED HISTORICAL FINANCIAL INFORMATION
    MANAGEMENT'S DISCUSSION AND ANALYSIS OF
      Components of Operating Expenses
    SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
      BENEFICIAL OWNERS
    DESCRIPTION OF ALLARITY DELAWARE CAPITAL STOCK
    CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS
    Certain Relationships and Related Person Transactions - ...
    Related Person Transactions Policy Following the ...
    EXPERTS
    LEGAL MATTERS
    INDEX TO FINANCIAL STATEMENTS
      Report of Independent Registered Public Accounting Firm
        BALANCE SHEET
        INCOME STATEMENT
        STOCKHOLDERS EQUITY
        CASH FLOW
      NOTES TO FINANCIAL STATEMENTS
        BALANCE SHEET
        STOCKHOLDERS EQUITY
        BALANCE SHEET
      Section 2.04 Withholding Rights. Each of the Exchange ...
        Compensation Issued Under a Company Stock Plan.
      Indemnification
    PART II
      Item 20. Indemnification of Directors and Officers
      Item 21. Exhibits and Financial Statement Schedules
      Item 22. Undertakings
    SIGNATURES
  EXHIBIT 3.4
    BYLAWS OF
    Section 7.04 Conflict with Applicable Law or Certificate of ...
  EXHIBIT 8.1
  EXHIBIT 10.5
  EXHIBIT 10.6
  EXHIBIT 10.7
  EXHIBIT 10.11
  EXHIBIT 10.12
  EXHIBIT 10.13
  EXHIBIT 23.1
    CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM